Hello and welcome to the details of AstraZeneca Covid-19 vaccine 76pc effective in updated US trial results and now with the details
Subscribe to our Telegram channel for the latest updates on news you need to know.
WASHINGTON, March 25 — AstraZeneca said today its Covid-19 vaccine was 76 per cent effective at preventing symptomatic illness, citing a new analysis of up-to-date results for its major US trial.
US health officials earlier in the week publicly rebuked the drugmaker for using “outdated information” when calculating that the vaccine was 79 per cent effective.
That marked a new setback for the vaccine that was once hailed as a milestone in the fight against the Covid-19 pandemic, but has been dogged by questions over its effectiveness and possible side-effects.
AstraZeneca reiterated today that the shot, developed with Oxford University, was 100 per cent effective against severe or critical forms of the disease.
It also said the vaccine showed 85 per cent efficacy in adults 65 years and older.
The latest trial data, which has yet to be reviewed by independent researchers or regulators, was based on 190 infections and 32,449 participants in the United States, Chile and Peru. The earlier interim data was based on 141 infections through February 17.
The updated 76 per cent efficacy rate compares with rates of about 95 per cent for vaccines from Pfizer/BioNTech and Moderna.
The AstraZeneca vaccine is, however, seen as crucial in tackling the spread of Covid-19 across the globe, not just due to limited vaccine supply but also because it is easier and cheaper to transport than rival shots. It has been granted conditional marketing or emergency use authorization in more than 70 countries.
The shot has faced questions since late last year when the drugmaker and Oxford University published data from an earlier trial with two different efficacy readings as a result of a dosing error.
Then this month, more than a dozen countries temporarily suspended giving out the vaccine after reports linked it to a rare blood clotting disorder in a very small number of people.
The European Union’s drug regulator said last week the vaccine was clearly safe, but Europeans remain sceptical about its safety. — Reuters
These were the details of the news AstraZeneca Covid-19 vaccine 76pc effective in updated US trial results for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.